annual D&A:
$1.24B+$78.59M(+6.77%)Summary
- As of today (August 20, 2025), NVO annual depreciation & amortization is $1.24 billion, with the most recent change of +$78.59 million (+6.77%) on December 31, 2024.
- During the last 3 years, NVO annual D&A has risen by +$395.13 million (+46.81%).
- NVO annual D&A is now at all-time high.
Performance
NVO Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$721.96M+$181.61M(+33.61%)Summary
- As of today (August 20, 2025), NVO quarterly depreciation & amortization is $721.96 million, with the most recent change of +$181.61 million (+33.61%) on June 1, 2025.
- Over the past year, NVO quarterly D&A has dropped by -$558.08 million (-43.60%).
- NVO quarterly D&A is now -43.60% below its all-time high of $1.28 billion, reached on June 30, 2024.
Performance
NVO quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$797.30M-$558.08M(-41.18%)Summary
- As of today (August 20, 2025), NVO TTM depreciation & amortization is $797.30 million, with the most recent change of -$558.08 million (-41.18%) on June 1, 2025.
- Over the past year, NVO TTM D&A has dropped by -$1.50 billion (-65.33%).
- NVO TTM D&A is now -65.33% below its all-time high of $2.30 billion, reached on June 30, 2024.
Performance
NVO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVO Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.8% | -43.6% | -65.3% |
| 3 y3 years | +46.8% | +209.0% | -12.0% |
| 5 y5 years | +76.7% | +322.2% | +13.2% |
NVO Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.8% | -43.6% | +191.6% | -65.3% | at low |
| 5 y | 5-year | at high | +76.7% | -43.6% | +191.6% | -65.3% | +13.2% |
| alltime | all time | at high | >+9999.0% | -43.6% | +191.6% | -65.3% | +696.9% |
NVO Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $721.96M(+33.6%) | $797.30M(-41.2%) |
| Mar 2025 | - | $540.35M(-168.6%) | $1.36B(+9.4%) |
| Dec 2024 | $1.24B(+6.8%) | -$788.24M(-343.9%) | $1.24B(-45.1%) |
| Sep 2024 | - | $323.23M(-74.7%) | $2.26B(-1.9%) |
| Jun 2024 | - | $1.28B(+201.8%) | $2.30B(+72.0%) |
| Mar 2024 | - | $424.19M(+85.2%) | $1.34B(+15.2%) |
| Dec 2023 | $1.16B(+24.4%) | $229.01M(-37.5%) | $1.16B(+5.6%) |
| Sep 2023 | - | $366.26M(+15.3%) | $1.10B(+8.2%) |
| Jun 2023 | - | $317.57M(+28.2%) | $1.02B(+9.0%) |
| Mar 2023 | - | $247.80M(+47.9%) | $931.69M(-0.1%) |
| Dec 2022 | $932.67M(+10.5%) | $167.60M(-40.7%) | $932.67M(-4.2%) |
| Sep 2022 | - | $282.65M(+21.0%) | $974.02M(+7.5%) |
| Jun 2022 | - | $233.66M(-6.1%) | $906.19M(+4.2%) |
| Mar 2022 | - | $248.77M(+19.1%) | $869.85M(+3.1%) |
| Dec 2021 | $844.09M(+4.6%) | $208.94M(-2.7%) | $844.09M(+7.7%) |
| Sep 2021 | - | $214.82M(+8.9%) | $783.91M(-12.5%) |
| Jun 2021 | - | $197.32M(-11.5%) | $896.03M(+3.0%) |
| Mar 2021 | - | $223.01M(+49.9%) | $869.70M(+7.8%) |
| Dec 2020 | $806.82M(+15.0%) | $148.76M(-54.5%) | $806.82M(+12.5%) |
| Sep 2020 | - | $326.94M(+91.2%) | $717.15M(+1.8%) |
| Jun 2020 | - | $170.99M(+6.8%) | $704.52M(+0.6%) |
| Mar 2020 | - | $160.13M(+171.0%) | $700.60M(-0.1%) |
| Dec 2019 | $701.43M(+16.3%) | $59.10M(-81.2%) | $701.43M(-20.3%) |
| Sep 2019 | - | $314.31M(+88.1%) | $879.82M(+28.0%) |
| Jun 2019 | - | $167.06M(+3.8%) | $687.36M(+6.9%) |
| Mar 2019 | - | $160.96M(-32.2%) | $643.05M(+6.7%) |
| Dec 2018 | $602.90M(+38.5%) | $237.49M(+94.9%) | $602.90M(+30.5%) |
| Sep 2018 | - | $121.85M(-0.7%) | $461.84M(+2.7%) |
| Jun 2018 | - | $122.76M(+1.6%) | $449.91M(-1.0%) |
| Mar 2018 | - | $120.81M(+25.3%) | $454.51M(+4.4%) |
| Dec 2017 | $435.19M(-4.5%) | $96.43M(-12.3%) | $435.19M(-10.1%) |
| Sep 2017 | - | $109.92M(-13.7%) | $484.08M(+0.1%) |
| Jun 2017 | - | $127.36M(+25.5%) | $483.67M(+4.0%) |
| Mar 2017 | - | $101.49M(-30.2%) | $464.96M(+2.0%) |
| Dec 2016 | $455.69M(+3.6%) | $145.32M(+32.7%) | $455.69M(-0.3%) |
| Sep 2016 | - | $109.51M(+0.8%) | $457.00M(+2.8%) |
| Jun 2016 | - | $108.65M(+17.8%) | $444.72M(+2.9%) |
| Mar 2016 | - | $92.21M(-37.1%) | $432.09M(-1.8%) |
| Dec 2015 | $439.92M(-11.6%) | $146.63M(+50.8%) | $439.92M(+50.0%) |
| Sep 2015 | - | $97.22M(+1.2%) | $293.29M(+49.6%) |
| Jun 2015 | - | $96.02M(-4.0%) | $196.07M(+96.0%) |
| Mar 2015 | - | $100.05M | $100.05M |
| Dec 2014 | $497.52M(+5.3%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $472.63M(+6.5%) | - | - |
| Dec 2012 | $443.99M(-4.5%) | - | - |
| Dec 2011 | $464.79M(+9.0%) | $127.83M(+12.1%) | $510.90M(+3.9%) |
| Sep 2011 | - | $114.03M(-27.8%) | $491.80M(+1.1%) |
| Jun 2011 | - | $157.99M(+42.3%) | $486.28M(+13.2%) |
| Mar 2011 | - | $111.05M(+2.1%) | $429.44M(+0.7%) |
| Dec 2010 | $426.27M(-0.9%) | $108.73M(+0.2%) | $426.27M(-5.2%) |
| Sep 2010 | - | $108.50M(+7.3%) | $449.77M(-5.9%) |
| Jun 2010 | - | $101.16M(-6.2%) | $477.85M(-0.2%) |
| Mar 2010 | - | $107.88M(-18.4%) | $478.92M(+0.3%) |
| Dec 2009 | $430.23M(-1.7%) | $132.23M(-3.2%) | $477.42M(+38.3%) |
| Sep 2009 | - | $136.58M(+33.6%) | $345.19M(+65.5%) |
| Jun 2009 | - | $102.23M(-3.9%) | $208.61M(+96.1%) |
| Mar 2009 | - | $106.37M | $106.37M |
| Dec 2008 | $437.65M(+14.9%) | - | - |
| Dec 2007 | $381.03M(+15.4%) | - | - |
| Dec 2006 | $330.33M(+12.7%) | - | - |
| Dec 2005 | $293.19M(+12.1%) | - | - |
| Dec 2004 | $261.50M(+16.8%) | - | - |
| Dec 2003 | $223.88M(+44.1%) | - | - |
| Dec 2002 | $155.33M(+19.7%) | - | - |
| Dec 2001 | $129.77M(+1.2%) | - | - |
| Dec 2000 | $128.24M(-36.8%) | - | - |
| Dec 1999 | $202.93M(-6.7%) | - | - |
| Dec 1998 | $217.51M(+26.1%) | - | - |
| Dec 1997 | $172.43M(-6.1%) | - | - |
| Dec 1996 | $183.69M(-9.8%) | - | - |
| Dec 1995 | $203.56M(+22.6%) | - | - |
| Dec 1994 | $166.02M(+35.1%) | - | - |
| Dec 1993 | $122.87M(+6.6%) | - | - |
| Dec 1992 | $115.32M(+24.8%) | - | - |
| Dec 1991 | $92.37M(+9.7%) | - | - |
| Dec 1990 | $84.16M(+30.4%) | - | - |
| Dec 1989 | $64.52M(+34.6%) | - | - |
| Dec 1988 | $47.93M(+24.0%) | - | - |
| Dec 1987 | $38.67M(+39.1%) | - | - |
| Dec 1986 | $27.80M(+47.9%) | - | - |
| Dec 1985 | $18.79M(+17.9%) | - | - |
| Dec 1984 | $15.93M(+10.1%) | - | - |
| Dec 1983 | $14.48M(+17.5%) | - | - |
| Dec 1982 | $12.32M(+10.9%) | - | - |
| Dec 1981 | $11.11M(-5.6%) | - | - |
| Dec 1980 | $11.78M | - | - |
FAQ
- What is Novo Nordisk A/S annual depreciation & amortization?
- What is the all time high annual D&A for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual D&A year-on-year change?
- What is Novo Nordisk A/S quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly D&A year-on-year change?
- What is Novo Nordisk A/S TTM depreciation & amortization?
- What is the all time high TTM D&A for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM D&A year-on-year change?
What is Novo Nordisk A/S annual depreciation & amortization?
The current annual D&A of NVO is $1.24B
What is the all time high annual D&A for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual depreciation & amortization is $1.24B
What is Novo Nordisk A/S annual D&A year-on-year change?
Over the past year, NVO annual depreciation & amortization has changed by +$78.59M (+6.77%)
What is Novo Nordisk A/S quarterly depreciation & amortization?
The current quarterly D&A of NVO is $721.96M
What is the all time high quarterly D&A for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly depreciation & amortization is $1.28B
What is Novo Nordisk A/S quarterly D&A year-on-year change?
Over the past year, NVO quarterly depreciation & amortization has changed by -$558.08M (-43.60%)
What is Novo Nordisk A/S TTM depreciation & amortization?
The current TTM D&A of NVO is $797.30M
What is the all time high TTM D&A for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM depreciation & amortization is $2.30B
What is Novo Nordisk A/S TTM D&A year-on-year change?
Over the past year, NVO TTM depreciation & amortization has changed by -$1.50B (-65.33%)